Australian biotech firm Tryptamine Therapeutics Limited (ASX: TYP) secured A$6 million in new funding through a strategic placement. The placement, priced at A$0.02 per share, was backed by cornerstone investors that included Merchant Biotech Fund and biotech investor Daniel Tillett, who will join the company’s board as a non-executive director, …
… Cannabis Regulatory Commission · New Jersey Passes Law to … [Webinar] Cannabis Legalization in New York: Implementation and Opportunities.
… marijuana, two on medical marijuana, and one on psychedelics. Voters in … Rhode Island • South Carolina • Virginia • West Virginia • Wisconsin.
… New York’s social equity program. The firm’s CEO, Peter Sack … New York’s expanding cannabis market. Top Psychedelic Company for Week.